Benign and malignant pulmonary parenchymal findings on chest CT among adult survivors of childhood and young adult cancer with a history of chest radiotherapy
- PMID: 37209240
- PMCID: PMC11973493
- DOI: 10.1007/s11764-023-01405-1
Benign and malignant pulmonary parenchymal findings on chest CT among adult survivors of childhood and young adult cancer with a history of chest radiotherapy
Abstract
Purpose: Childhood and young adult cancer survivors exposed to chest radiotherapy are at increased risk of lung cancer. In other high-risk populations, lung cancer screening has been recommended. Data is lacking on prevalence of benign and malignant pulmonary parenchymal abnormalities in this population.
Methods: We conducted a retrospective review of pulmonary parenchymal abnormalities in chest CTs performed more than 5 years post-cancer diagnosis in survivors of childhood, adolescent, and young adult cancer. We included survivors exposed to radiotherapy involving the lung field and followed at a high-risk survivorship clinic between November 2005 and May 2016. Treatment exposures and clinical outcomes were abstracted from medical records. Risk factors for chest CT-detected pulmonary nodule were assessed.
Results: Five hundred and ninety survivors were included in this analysis: median age at diagnosis, 17.1 years (range, 0.4-39.8); and median time since diagnosis, 22.3 years (range, 1-58.6). At least one chest CT more than 5 years post-diagnosis was performed in 338 survivors (57%). Among these, 193 (57.1%) survivors had at least one pulmonary nodule detected on a total of 1057 chest CTs, resulting in 305 CTs with 448 unique nodules. Follow-up was available for 435 of these nodules; 19 (4.3%) were malignant. Risk factors for first pulmonary nodule were older age at time of CT, CT performed more recently, and splenectomy.
Conclusions: Benign pulmonary nodules are very common among long-term survivors of childhood and young adult cancer.
Implications for cancer survivors: High prevalence of benign pulmonary nodules in cancer survivors exposed to radiotherapy could inform future guidelines on lung cancer screening in this population.
Keywords: Cancer survivor; Chest CT; Lung cancer; Pulmonary nodule.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Figures
Update of
-
Benign and Malignant Findings on Chest CT Among Adult Survivors of Childhood and Young Adult Cancer with a History of Chest Radiotherapy.Res Sq [Preprint]. 2023 Feb 21:rs.3.rs-2599972. doi: 10.21203/rs.3.rs-2599972/v1. Res Sq. 2023. Update in: J Cancer Surviv. 2024 Oct;18(5):1657-1664. doi: 10.1007/s11764-023-01405-1. PMID: 36865217 Free PMC article. Updated. Preprint.
Similar articles
-
Benign and Malignant Findings on Chest CT Among Adult Survivors of Childhood and Young Adult Cancer with a History of Chest Radiotherapy.Res Sq [Preprint]. 2023 Feb 21:rs.3.rs-2599972. doi: 10.21203/rs.3.rs-2599972/v1. Res Sq. 2023. Update in: J Cancer Surviv. 2024 Oct;18(5):1657-1664. doi: 10.1007/s11764-023-01405-1. PMID: 36865217 Free PMC article. Updated. Preprint.
-
Risk of Malignancy in Incidentally Detected Lung Nodules in Patients Aged Younger Than 35 Years.J Comput Assist Tomogr. 2024 Sep-Oct 01;48(5):770-773. doi: 10.1097/RCT.0000000000001592. Epub 2024 Feb 27. J Comput Assist Tomogr. 2024. PMID: 38438334 Free PMC article.
-
Do characteristics of pulmonary nodules on computed tomography in children with known osteosarcoma help distinguish whether the nodules are malignant or benign?J Pediatr Surg. 2011 Apr;46(4):729-735. doi: 10.1016/j.jpedsurg.2010.11.027. J Pediatr Surg. 2011. PMID: 21496545 Free PMC article.
-
Evaluating the Patient With a Pulmonary Nodule: A Review.JAMA. 2022 Jan 18;327(3):264-273. doi: 10.1001/jama.2021.24287. JAMA. 2022. PMID: 35040882 Review.
-
Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Eur J Cancer. 2021 Oct;156:127-137. doi: 10.1016/j.ejca.2021.06.021. Epub 2021 Aug 24. Eur J Cancer. 2021. PMID: 34450551
References
-
- McIntyre A, Ganti AK. Lung cancer-a global perspective. J Surg Oncol. 2017;115:550–4. - PubMed
-
- Moyer VA, U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:330–8. - PubMed
-
- Kinsinger LS, Anderson C, Kim J, Larson M, Chan SH, King HA, et al. Implementation of lung cancer screening in the veterans health administration. JAMA Intern Med. 2017;177:399–406. - PubMed
-
- Miller AT, Kruger P, Conner K, Robertson T, Rowley B, Sause W, et al. Initial outcomes of a lung cancer screening program in an integrated community health system. J Am Coll Radiol. 2016;13:733–7. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials